Eye Therapy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/253,736, filed Oct 21, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,870,934 | Eye Therapy System In force · High confidence | Avedro, Inc. | In force | High confidence | ||
| US 9,707,126 | Systems and Methods for Corneal Cross-Linking with Pulsed Light In force · High confidence | Avedro, Inc. | In force | High confidence | ||
| US 8,574,277 | Eye Therapy In force · High confidence | Avedro, Inc. | In force | High confidence | ||
| US 9,498,642 | Eye Therapy System In force · High confidence | Avedro, Inc. | In force | High confidence | ||
| US 9,044,308 | Systems and Methods for Reshaping an Eye Feature In force · High confidence | Avedro, Inc. | In force | High confidence | ||
| Application 13/841,617 | Systems and Methods for Corneal Cross-Linking with Pulsed Light Abandoned Abandoned Jun 5, 2018 | Avedro, Inc. | Abandoned | Abandoned Jun 5, 2018 | not computed | |
| Application 14/072,640 | Systems and Methods for Corneal Cross-Linking with Pulsed Light Abandoned Abandoned Mar 30, 2018 | Avedro, Inc. | Abandoned | Abandoned Mar 30, 2018 | not computed |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Avedro, Inc..
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.